ESTUDIO SUSTANCIAS ANTAGONISTAS PRODUCIDAS POR MICROORGANISMOS
ESTUDIO SUSTANCIAS ANTAGONISTA
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Virgen de las Nieves (19)
2024
-
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants
npj Genomic Medicine, Vol. 9, Núm. 1
2023
-
Circular and L50-like leaderless enterocins share a common ABC-transporter immunity gene
BMC Genomics, Vol. 24, Núm. 1
2022
-
Autophagy in Hematological Malignancies
Cancers, Vol. 14, Núm. 20
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Antimicrobial activity of the circular bacteriocin as-48 against clinical multidrug-resistant staphylococcus aureus
Antibiotics, Vol. 10, Núm. 8
-
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085
-
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Scientific Reports, Vol. 11, Núm. 1
-
Polymorphisms within autophagy‐related genes influence the risk of developing colorectal cancer: A meta‐analysis of four large cohorts
Cancers, Vol. 13, Núm. 6, pp. 1-15
-
Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium
Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17
2020
-
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium
Scientific Reports, Vol. 10, Núm. 1
-
Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis
Infection and Immunity, Vol. 88, Núm. 4
2019
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
-
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
Scientific Reports, Vol. 9, Núm. 1
2018
-
Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme
Scientific Reports, Vol. 8, Núm. 1
2017
-
Optimization of genotypic and biochemical methods to profile P. acnes isolates from a patient population
Journal of Microbiological Methods, Vol. 141, pp. 17-24
-
Regulation of Fn14 receptor and NF-κB underlies inflammation in Meniere's disease
Frontiers in Immunology, Vol. 8, Núm. DEC
2015
-
Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium
Endocrine-Related Cancer, Vol. 22, Núm. 4, pp. 545-559
2004
-
BacTregulators: A database of transcriptional regulators in bacteria and archaea
Bioinformatics, Vol. 20, Núm. 16, pp. 2787-2791